Gadobutrol for Healthy Subjects

This trial tests the safety and effectiveness of a special dye called gadobutrol, injected into the fluid around the brain and spinal cord. Researchers aim to determine if this dye enhances MRI images of fluid flow and drainage. A suitable participant is a healthy adult who can stay in a clinic for 3 days and has undergone pre-screening under a specific NIH protocol. Participants will undergo MRIs and provide blood and urine samples to help scientists better understand the brain's fluid dynamics. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative approach.

The trial does not specify if you need to stop taking your current medications, but if you are on anti-coagulation therapy, you cannot participate.

In a previous study, researchers administered gadobutrol to over 23,000 patients. Side effects related to the drug appeared in 2.5% of patients, with serious side effects in only 0.02%. The most common complaints included nausea and a metallic taste. Another study involved 79 patients who received a specific dose, and no side effects were reported.

Gadobutrol is unique because it is a contrast agent used in imaging, specifically for enhancing MRI scans, and it is being explored for its safety and effectiveness in healthy volunteers. Unlike other MRI contrast agents, Gadobutrol has a high concentration, which allows for a smaller volume to be used while still providing clear images. Researchers are excited about this treatment because its potential for reducing dosage without compromising image quality could lead to safer and more efficient diagnostic procedures.

Research has shown that gadobutrol enhances the clarity of MRI images. It has been used successfully to examine conditions such as multiple sclerosis and brain tumors. Studies indicate that gadobutrol provides sharp and detailed images, aiding doctors in understanding internal conditions. It is considered safe and well-tolerated by many patients, even those with various health issues. Specifically, studies involving over 23,000 people have confirmed its safety. This makes gadobutrol a reliable choice for improving MRI scans by providing better contrast and clarity. Participants in this trial will receive gadobutrol to further evaluate its effects in healthy volunteers.⁶⁷⁸⁹¹⁰